Research prioritisation in preparedness for and response to outbreaks of high-consequence pathogens: a scoping review
Antonio E. et al, (2025), BMC Medicine, 23
Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational study
Kasbergen LMR. et al, (2025), The Lancet Infectious Diseases
Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational study
Sigfrid L. et al, (2025), The Lancet Infectious Diseases
Monkeypox virus isolation from longitudinal samples in 11 hospitalised patients.
Callaby H. et al, (2024), The Lancet. Infectious diseases
Long Covid: a global health issue - a prospective, cohort study set in four continents.
Pazukhina E. et al, (2024), BMJ global health, 9
Prevalence, risk factors, and impact of long COVID in a socially vulnerable community in Brazil: a prospective cohort study
Azambuja P. et al, (2024), The Lancet Regional Health - Americas, 37
At-admission prediction of mortality and pulmonary embolism in an international cohort of hospitalised patients with COVID-19 using statistical and machine learning methods.
Mesinovic M. et al, (2024), Scientific reports, 14
Preparedness and response for emerging infectious diseases
Farnon EC. et al, (2024), Emerging and Re-emerging Infections in Travellers, 19 - 39
Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms
Citarella BW. et al, (2024), Heliyon, 10, e29591 - e29591
Scoping review protocol on research prioritisation for preparedness and response to outbreaks of high consequence pathogens
Antonio E. et al, (2024), Open Research Europe, 3, 16 - 16
Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
Michael BD. et al, (2024), Nature Communications, 15
Improving coherence of global research funding: Pandemic PACT
Norton A. et al, (2024), The Lancet, 403, 1233 - 1233
International Care programs for Pediatric Post-COVID Condition (Long COVID) and the way forward
Brackel CLH. et al, (2024), Pediatric Research
Long-term neurological symptoms after acute COVID-19 illness requiring hospitalization in adult patients: insights from the ISARIC-COVID-19 follow-up study.
Battaglini D. et al, (2024), Journal of neurology, 271, 79 - 86
Short-term and medium-term clinical outcomes of multisystem inflammatory syndrome in children: a prospective observational cohort study.
Glazyrina A. et al, (2024), Italian journal of pediatrics, 50
Delayed mucosal anti-viral responses despite robust peripheral inflammation in fatal COVID-19.
Sidhu JK. et al, (2023), The Journal of infectious diseases
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.
Michael BD. et al, (2023), Nature communications, 14
Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera
Roper KJ. et al, (2023), Scientific Reports, 13
A multi-country analysis of COVID-19 hospitalizations by vaccination status
Gonçalves BP. et al, (2023), Med, 4, 797 - 812.e2
Long COVID research: an update from the PHOSP-COVID Scientific Summit.
Brightling CE. et al, (2023), The Lancet. Respiratory medicine, 11, e93 - e94
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.
Taquet M. et al, (2023), Nature medicine, 29, 2498 - 2508
Implementable Deep Learning for Multi‐sequence Proton MRI Lung Segmentation: A Multi‐center, Multi‐vendor, and Multi‐disease Study
Astley JR. et al, (2023), Journal of Magnetic Resonance Imaging, 58, 1030 - 1044
International Pediatric COVID-19 Severity Over the Course of the Pandemic
Zhu Y. et al, (2023), JAMA Pediatrics, 177, 1073 - 1073
Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study.
Reyes LF. et al, (2023), Journal of critical care, 77
A review of new challenges and solutions to the timely and effective implementation of clinical research responses to high priority diseases of epidemic and pandemic potential: A scoping review protocol
Kadri-Alabi Z. et al, (2023), Open Research Europe, 3, 139 - 139
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
Baillie JK. et al, (2023), The Lancet Respiratory Medicine
Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID-19 cohort.
Shah N. et al, (2023), Artificial organs, 47, 1490 - 1502
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study
Jackson C. et al, (2023), The Lancet Respiratory Medicine, 11, 673 - 684
Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Pairo-Castineira E. et al, (2023), Nature, 619, E61 - E61
How funders can support improved clinical trial practice for outbreaks.
Foster I. et al, (2023), Lancet (London, England), 402
Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priority VHFs
Rigby I. et al, (2023), The Lancet Infectious Diseases, 23, e240 - e252
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry.
Griffee MJ. et al, (2023), Research and practice in thrombosis and haemostasis, 7
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls
Zheng B. et al, (2023), The Lancet Regional Health - Europe, 29, 100635 - 100635
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
Pairo-Castineira E. et al, (2023), Nature, 617, 764 - 768
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19.
Wainstein M. et al, (2023), Kidney international reports
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376
Neurological manifestations of COVID-19 in adults and children.
Cho S-M. et al, (2023), Brain : a journal of neurology, 146, 1648 - 1661
Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19.
Siggins MK. et al, (2023), Immunology, 168, 473 - 492
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study
McAuley HJC. et al, (2023), eClinicalMedicine, 57, 101896 - 101896
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection.
Goldswain H. et al, (2023), Genome biology, 24
The diagnostic accuracy of rapid diagnostic tests for Ebola virus disease: a systematic review
Dagens AB. et al, (2023), Clinical Microbiology and Infection, 29, 171 - 181
Scoping review protocol on research prioritisation for preparedness and response to outbreaks of high consequence pathogens
Antonio E. et al, (2023), Open Research Europe, 3, 16 - 16
Characteristics and risk factors for post-COVID-19 breathlessness after hospitalisation for COVID-19.
Daines L. et al, (2023), ERJ open research, 9, 274 - 2022
Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus study
Gorst SL. et al, (2023), The Lancet Respiratory Medicine
Liver injury in hospitalized patients with COVID-19: An International observational cohort study.
Tirupakuzhi Vijayaraghavan BK. et al, (2023), PloS one, 18
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
Liew F. et al, (2023), eBioMedicine, 87, 104402 - 104402
Scoping review protocol on research prioritisation for preparedness and response to outbreaks of high consequence pathogens.
Antonio E. et al, (2023), Open research Europe, 3